N. Taback

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
N. Taback, Nathan Taback, Nathan Asher Taback, Nathan A Taback, N Taback
Publication record
76 papers · 2,659 citations · H-index 21

PAPERS

Machine Learning to Allocate Palliative Care Consultations During Cancer Treatment
20246 citationsauthor #6
Equity, diversity, and inclusion in sports analytics
20222 citationsauthor #5
A Randomized Study to Evaluate the Effect of a Nudge via Weekly E-mails on Students’ Attitudes Toward Statistics
20224 citationsauthor #1
Design and Analysis of Experiments and Observational and Studies using R
20221 citationsauthor #1
multiverse: Multiplexing Alternative Data Analyses in R Notebooks
202124 citationsauthor #4
The Building Blocks of Statistical Education in the Data Science Ecosystem
20211 citationsauthor #2
Evaluation of Adolescents' and Young Adults' Attitudes Toward Participation in Cancer Clinical Trials.
202011 citationsauthor #8
Medical oncologists’ and palliative care physicians’ opinions towards thromboprophylaxis for inpatients with advanced cancer: a cross-sectional study
20194 citationsauthor #2
ANNUAL MEETING ON SUPPORTIVE CARE IN CANCER
20189 citationsauthor #1
Factors associated with imaging in patients with early breast cancer after initial treatment.
201810 citationsauthor #6
Reliability of administrative data for evaluating quality of systemic cancer treatment.
20170 citationsauthor #3
Reliability of administrative data for evaluating the quality of systemic treatment for cancer.
20171 citationsauthor #2
Evaluation of adolescents and young adults (AYA) attitudes towards participation in cancer clinical trials.
20175 citationsauthor #7
Establishing achievable benchmarks for quality improvement in systemic therapy for early‐stage breast cancer
20179 citationsauthor #5
Setting Quality Improvement Priorities for Women Receiving Systemic Therapy for Early-Stage Breast Cancer by Using Population-Level Administrative Data.
201712 citationsauthor #2
Identifying opportunities to improve quality of cancer care: An evaluation of the use of diagnostic imaging in women curatively treated for early breast cancer (EBC).
20160 citationsauthor #6
Setting quality improvement priorities for women receiving systemic therapy (ST) for early stage breast cancer (EBC) using population level administrative data.
20160 citationsauthor #4
Time to Viremia for Patients Taking their First Antiretroviral Regimen and the Subsequent Resistance Profiles
20161 citationsauthor #5
Establishing achievable benchmarks for quality improvement in systemic therapy for early-stage breast cancer.
20160 citationsauthor #4
Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer.
2015139 citationsauthor #4
Impact of age on the quality of systemic therapy delivery in older patients with early breast cancer (EBC).
20150 citationsauthor #4
Use and impact of intermittent versus continuous systemic treatment strategies in metastatic colorectal cancer in routine practice
20153 citationsauthor #3
Invasive procedures in the elderly after stage IV cancer diagnosis.
201520 citationsauthor #6
Time to virologic failure for patients taking their first antiretroviral regimen and the subsequent resistance profiles
20141 citationsauthor #5
Validating Billing/Encounter Codes as Indicators of Lung, Colorectal, Breast, and Prostate Cancer Recurrence Using 2 Large Contemporary Cohorts
2014119 citationsauthor #3
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study.
201421 citationsauthor #3
Interinstitutional Variation in Management Decisions for Treatment of 4 Common Types of CancerA Multi-institutional Cohort StudyInterinstitutional Variation in Cancer Management Decisions
20144 citationsauthor #3
Use and impact of chemotherapy-free intervals in metastatic colorectal cancer in routine practice.
20131 citationsauthor #3
Trends in combined coronary artery calcium (CAC) and myocardial perfusion imaging (MPI) with SPECT/CT
20130 citationsauthor #3
Identifying opportunities to improve quality of cancer care: An evaluation of the use of routine surveillance imaging scans in women with early breast cancer (EBC) treated in Ontario, Canada.
20130 citationsauthor #3
Abstracts from the 33rd Annual Scientific Meeting of the Canadian Geriatrics Society Toronto, April 2013
20130 citationsauthor #167
Impact of oncology‐related direct‐to‐consumer advertising
201313 citationsauthor #3
Intensity of palliative care and its impact on the aggressiveness of end-of-life care in patients with advanced pancreatic cancer.
20133 citationsauthor #4
The use of routine surveillance imaging scans in women with early breast cancer (EBC) treated in Ontario, Canada.
20130 citationsauthor #4
Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States.
201364 citationsauthor #4
Pathological predictors for site of local recurrence after radiotherapy for prostate cancer.
201261 citationsauthor #3
Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance.
201250 citationsauthor #2
Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study.
2012484 citationsauthor #4
High-cost imaging in elderly patients with stage IV cancer.
201235 citationsauthor #4
End-of-Life Care Discussions Among Patients With Advanced Cancer
2012305 citationsauthor #3
Accelerated partial-breast irradiation using brachytherapy (APBIb) for breast cancer (BCA): Predictors of use and guideline concordance.
20111 citationsauthor #2
Accelerated partial breast irradiation using brachytherapy (APBIb) for breast cancer (bca): Predictors of use and guideline concordance.
20112 citationsauthor #2
Use of Stereotactic Radiosurgery for Brain Metastases: A SEER-Medicare Analysis
20114 citationsauthor #4
Discussions about end-of-life care planning between physicians and patients with stage IV lung or colorectal cancer.
20110 citationsauthor #3
A population-based assessment of the risk of fragility fracture associated with the use of adjuvant hormone therapy for early breast cancer in older women.
20111 citationsauthor #3
Use of high-cost imaging in elderly patients with metastatic cancer.
20110 citationsauthor #4
Investigator experiences with financial conflicts of interest in clinical trials
201134 citationsauthor #14
Adverse pregnancy outcomes among foreign-born Canadians.
201138 citationsauthor #3
Effect of bodychecking on rate of injuries among minor hockey players
201162 citationsauthor #2
Utilization Of High Cost Imaging In Stage IV Cancer Patients
20110 citationsauthor #4
Invasive Procedures In Stage IV Cancer Patients
20110 citationsauthor #5
Institutional financial conflicts of interest policies at Canadian academic health science centres: a national survey
201013 citationsauthor #14
Financial Conflicts of Interest Checklist 2010 for clinical research studies
201031 citationsauthor #14
Bereavement practices of physicians in oncology and palliative care.
200954 citationsauthor #4
Poor Reporting of Scientific Leadership Information in Clinical Trial Registers
200845 citationsauthor #9
National Evaluation of Policies on Individual Financial Conflicts of Interest in Canadian Academic Health Science Centers
200812 citationsauthor #14
A survey of abstracts of high-impact clinical journals indicated most statistical methods presented are summary statistics.
200811 citationsauthor #1
The Dirty War Index: Statistical Issues, Feasibility, and Interpretation
20088 citationsauthor #1
Sexual violence in the Democratic Republic of the Congo.
200836 citationsauthor #1
Commentary
20080 citationsauthor #1
Bereavement practices of Canadian cancer physicians
20080 citationsauthor #4
Mortality of journalists in Iraq
20070 citationsauthor #1
Potential drug interactions and duplicate prescriptions among cancer patients.
2007319 citationsauthor #5
Source of funding, conflict of interest (COI), and the interpretation of cancer clinical trials
20074 citationsauthor #3
The science of human security
200712 citationsauthor #1
Validation of the genital herpes treatment satisfaction questionnaire (GHerpTSQ) in status and change versions
200613 citationsauthor #1
SECURITY OF JOURNALISTS: MAKING THE CASE FOR MODELLING ARMED VIOLENCE AS A MEANS TO PROMOTE HUMAN SECURITY
200610 citationsauthor #1
N.P.4 09 Percutaneous gastrostomy in Werdnig–Hoffman disease
20060 citationsauthor #4
Enterostomy tube placement in children with spinal muscular atrophy type 1.
200614 citationsauthor #3
Towards Collation and Modelling of the Global Cost of Armed Violence on Civilians
200517 citationsauthor #1
Time scale and other invariants of integrative mechanical behavior in living cells.
2003386 citationsauthor #6
SMALL SAMPLE INFERENCE IN LOCATION SCALE MODELS WITH STUDENT(λ) ERRORS
20022 citationsauthor #1
Ultrasound biomicroscopic quantitative analysis of light-dark changes associated with pupillary block.
199925 citationsauthor #4
Risk factors for pain and nausea following retinal and vitreous surgery under conscious sedation.
199927 citationsauthor #2
Adolescent substance use disorders: findings from a 14-year follow-up of speech/language-impaired and control children.
199957 citationsauthor #8
Likelihood asymptotics and location-scale-shape analysis
19981 citationsauthor #1

TIMELINE

1998 1 citations

1999 109 citations

2002 2 citations

2003 386 citations

2005 17 citations

2006 37 citations

2007 335 citations

2008 112 citations

2009 54 citations

2010 44 citations

2011 142 citations

2012 935 citations

2013 81 citations

2014 145 citations

2015 162 citations

2016 1 citations

2017 27 citations

2018 19 citations

2019 4 citations

2020 11 citations

2021 25 citations

2022 7 citations

2024 6 citations

COAUTHOR MAP

CONCEPT FOOTPRINT